Home > Insider Trading > Filing (0001237899-12-000110)

Filing Details

Accession Number:: 0001237899-12-000110
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-12-20 16:17:48
Reporting Period:: 2012-12-18

Filing Date:: 2012-12-20
Accepted Time:: 2012-12-20 16:17:48
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
872589	Regeneron Pharmaceuticals Inc	REGN	Pharmaceutical Preparations (2834)	133444607

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1377247	Peter Powchik	777 Old Saw Mill River Road Tarrytown NY 10591	Svp Clin Devel & Reg Affairs	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2012-12-18	8,000	$52.03	22,990	No	4	M	Direct
Common Stock	Disposition	2012-12-18	2,330	$178.62	20,660	No	4	F	Direct
Common Stock	Disposition	2012-12-18	2,612	$178.62	18,048	No	4	F	Direct
Common Stock	Acquisiton	2012-12-18	16,000	$30.63	34,048	No	4	M	Direct
Common Stock	Disposition	2012-12-18	2,743	$178.62	31,305	No	4	F	Direct
Common Stock	Disposition	2012-12-18	6,107	$178.62	25,198	No	4	F	Direct
Common Stock	Acquisiton	2012-12-18	14,248	$21.25	39,446	No	4	M	Direct
Common Stock	Disposition	2012-12-18	1,694	$178.62	37,752	No	4	F	Direct
Common Stock	Disposition	2012-12-18	5,783	$178.62	31,969	No	4	F	Direct
Common Stock	Disposition	2012-12-19	1,034	$176.79	30,935	No	4	S	Direct
Common Stock	Disposition	2012-12-19	4,266	$177.52	26,669	No	4	S	Direct
Common Stock	Disposition	2012-12-19	2,200	$178.33	24,469	No	4	S	Direct
Common Stock	Disposition	2012-12-19	1,000	$179.56	23,469	No	4	S	Direct
Common Stock	Disposition	2012-12-19	1,256	$180.62	22,213	No	4	S	Direct
Common Stock	Disposition	2012-12-19	100	$181.25	22,113	No	4	S	Direct
Common Stock	Disposition	2012-12-19	500	$183.13	21,613	No	4	S	Direct
Common Stock	Disposition	2012-12-20	4,623	$170.44	16,990	No	4	S	Direct
Common Stock	Disposition	2012-12-20	2,000	$171.11	14,990	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	F	Direct
No	4	F	Direct
No	4	M	Direct
No	4	F	Direct
No	4	F	Direct
No	4	M	Direct
No	4	F	Direct
No	4	F	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2012-12-18	14,248	$0.00	14,248	$21.25
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2012-12-18	16,000	$0.00	16,000	$30.63
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2012-12-18	8,000	$0.00	8,000	$52.03

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
30,295	2019-12-18	No	4	M	Direct
12,736	2020-12-14	No	4	M	Direct
22,079	2021-12-16	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,532	Indirect	By 401(k) Plan

Footnotes

Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
Represents volume-weighted average price of sales of 1,034 shares of Company stock on December 19, 2012 at prices ranging from $176.72 to $176.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 19, 2012 at each separate price.
Represents volume-weighted average price of sales of 4,266 shares of Company stock on December 19, 2012 at prices ranging from $177.03 to $177.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 19, 2012 at each separate price.
Represents volume-weighted average price of sales of 2,200 shares of Company stock on December 19, 2012 at prices ranging from $178.00 to $178.66. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 19, 2012 at each separate price.
Represents volume-weighted average price of sales of 1,000 shares of Company stock on December 19, 2012 at prices ranging from $179.25 to $179.79. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 19, 2012 at each separate price.
Represents volume-weighted average price of sales of 1,256 shares of Company stock on December 19, 2012 at prices ranging from $180.04 to $180.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 19, 2012 at each separate price.
Represents volume-weighted average price of sales of 4,623 shares of Company stock on December 20, 2012 at prices ranging from $170.01 to $170.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 20, 2012 at each separate price.
Represents volume-weighted average price of sales of 2,000 shares of Company stock on December 120, 2012 at prices ranging from $1761.00 to $171.20. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 20, 2012 at each separate price.
The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant.
Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is/are not applicable in this case.